S2 Part 1: Processing and minor processing

Published Date: 16 Feb 2023

Dr. Jacob Sands and Dr. Jared Weiss talk about subtypes. ongoing clinical trials; sustained sustained response to treatment; And it is possible to use the word "cure" to treat a small breast cancer.

Read Full News

Latest News

ACC 2026: Anticipating New Data in Amyloid and ATTR-CM

Dr Kevin M. Alexander prepares for updates on amyloid research, real-world evidence, and imaging biomarkers.

What the 'Relax Your Tight End' Super Bowl Ad Got Wrong

PSA tests are never 'simple.' Dr Kenny Lin discusses how to move beyond overdiagnosis toward truly informed prostate cancer screening.

EoE on the Rise: What Every Endoscopist Should Know

Dr David Johnson highlights the recommendations most likely to change how you endoscopically manage this increasingly prevalent disease.

Staying the Course After EGFR Progression

Dr Mark Kris highlights a recent study on osimertinib in NSCLC and outlines the best approaches for treatment beyond progression.

AI in Medicine Desperately Needs Less Hype and More Honesty

A Yale School of Medicine professor argues that total transparency is the only way AI can become a trustworthy tool for physicians and patients.

Todays Updates

Older Adults With Advanced Cancer Prioritize Quality of Life

Most older adults with advanced cancer value quality of life over extending survival, but that preference may not translate to clinical care or outcomes.

Todays Updates

Older Adults With Advanced Cancer Prioritize Quality of Life

Most older adults with advanced cancer value quality of life over extending survival, but that preference may not translate to clinical care or outcomes.

Latest News

Dr Kevin M. Alexander prepares for updates on amyloid research, real-world evidence, and imaging biomarkers.

PSA tests are never 'simple.' Dr Kenny Lin discusses how to move beyond overdiagnosis toward truly informed prostate cancer screening.

Dr David Johnson highlights the recommendations most likely to change how you endoscopically manage this increasingly prevalent disease.

Dr Mark Kris highlights a recent study on osimertinib in NSCLC and outlines the best approaches for treatment beyond progression.

A Yale School of Medicine professor argues that total transparency is the only way AI can become a trustworthy tool for physicians and patients.

News All Time

S2 Episode 5: HER2 Low Testing in the ADC Era

Drs Kathy Miller and Sunil Badve discuss how HER2 testing has evolved over time as the need for that clinical testing has shifted, including assay limits, biology, and clinical impact.

HF With Improved Ejection Fraction

Heart Failure with Improved ejection fraction is characterized by previously reduced left ventricular ejection fraction (≤40%) that subsequently improves to >40%. This review highlight existing clinical gaps and proposes future research directions to refine risk stratification and therapeutic approaches for this evolving HF population.

S2 Episode 6: A Futuristic Vision for Treating Myelofibrosis

What will the next decade bring for myelofibrosis care? Drs Jain and Pemmaraju explore futuristic therapies, earlier interventions, and smarter diagnostics.

Radiofrequency Ablation: A First-Line Treatment Option

Drs Kaniksha Desai and Iram Hussain discuss the use of radiofrequency ablation for the treatment of hyperthyroidism.

S2 Episode 5: DNA Repair and Replication Stress in Endometrial Cancer

Drs Ursula A. Matulonis and Joyce F. Liu discuss targeting DNA damage and repair and replication stress in endometrial cancer.

May 09 2025 This Week in Cardiology

The controversial KETO-CTA study, tough decisions in subclinical AF, and another potentially huge benefit for GLP-1 agonist drugs are discussed by John Mandrola, MD, in this week’s podcast.

Should All Newborns Be Screened for Congenital Hypothyroidism?

Drs Kaniksha Desai and Larry Fox discuss congenital hypothyroidism, including when to test and how to treat it.

S2 Episode 4: Immunotherapy Insights and Research in Endometrial Cancer

Drs Ursula A. Matulonis and Gini F. Fleming discuss the state of endometrial cancer, the role of immunotherapy, and priorities for research in this field.

USCAP 2025

Read clinically focused news coverage of key developments from USCAP 2025

S3 Episode 3: The 2025 updates of the American Diabetes Association

Drs Carol H. Wysham and Rozalina G. McCoy discuss the 2025 updates of the American Diabetes Association, including comorbidities, dental care, sexual dysfunction, and CGM use.

Episode 2: New Guidelines and the Lupus Nephritis Kidney Conundrum

Join Drs Maureen McMahon and Brad Rovin as they discuss the KDIGO, ACR and EULAR guidelines as they relate to lupus nephritis.

Episode 1: Lupus by the Numbers: What the Data Reveals

Join Drs Maureen McMahon and Peter Izmirly as they discuss lupus epidemiology, and why knowing the data is especially important for physicians on the frontlines of healthcare.

S2 Episode 3: Molecular Classification and Genetics of Endometrial Cancer

Drs Ursula A. Matulonis and Katherine Fuh discuss the molecular classification and genetics of endometrial cancer as well as when to rebiopsy, research updates, and what's to come in the future.

The Interpretation and Management of Hypocalcemia

Mood change, neuropsychiatric symptoms, muscle cramps, or spasm are common in patients with this condition.

S2 Episode 2: Diet, Exercise, and Myelofibrosis: A Holistic Approach

Join Drs Tania Jain and Krisstina Gowin as they discuss the role integrative medicine plays in the treatment of myelofibrosis.

S3 Episode 1: MASLD and Type 2 Diabetes: Screening and Management

Drs Carol H. Wysham and Scott Isaacs discuss incorporating the screening and management of metabolic dysfunction-associated steatotic liver disease in endocrine practice.

Recommended News For You

What is Mohs micrographic surgery? 8 FAQs about Mohs

Anticoagulation for 12 months has been found to improve outcomes in cancer patients with minor blood clots.

Let's Talk Breast Density; Cancer, Movies, and Music; Treatment-Induced Aging?

Safe and acceptable telehealth suicide prevention program.

Perioperative Anti-PD-1 in Soft-Tissue Sarcoma Boosts Disease-Free Survival

Five new papers highlight cancer inequities, challenges and opportunities in South Asia

Studies have shown that physical activity prevents cancer in patients who have been treated for cancer in the past.

Recommended Articles For You

A New Dawn for Triple-Negative Breast Cancer: Emerging Therapies and the Art of Healing 

Liquid Biopsy: Revolutionizing Precision Oncology in Hematological Malignancies 

Unlocking the Potential of Glofitamab: A Novel Treatment for Cancer 

Unlocking the Mystery of Glanzmann Thrombasthenia: A New Hope for Patients 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The Predictive Power of Liquid Biopsy in Colon Cancer Outcomes Is Inconsistent.

2.

Advancing Health in Africa

3.

A new device enhances liquid biopsy.

4.

Stereotactic Radiation Linked to Better Brain Mets Outcomes

5.

In heavily pretreated DLBCL, Triplet Scores a Survival Victory.

1.

Understanding Blood Dyscrasia: Symptoms, Causes and Treatment Options

2.

Checkpoint Inhibitors in Oncology: Advances in PD-1/PD-L1 and CTLA-4 Targeted Therapy

3.

New Hope for Rectal Cancer Patients: Breakthrough Drug Shows Promising Results

4.

The New Frontier of Cancer Survivorship: Navigating the Long-Term Effects of Immunotherapy and Targeted Therapies

5.

Unlocking the Benefits of Cyramza: A New Frontier in Cancer Treatment

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Current Scenario of Cancer- Palliative Care to Close the Care Gap

2.

From Relapse to Remission: Mapping the Treatment Journey in Adult R/R-Cell ALL - Part 2

3.

Beyond the Mutation: Addressing the Unmet Needs in ALK-Positive NSCLC

4.

Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part I

5.

Oropharyngeal Cancer in Relation to HPV Status

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot